Join to View Full Profile
4921 Parkview PlSt. Louis, MO 63110
Phone+1 314-747-1171
Fax+1 314-362-3192
Dr. Linette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1997
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1995- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1992
Georgetown University School of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 2016 - 2026
MO State Medical License 2001 - 2017
MA State Medical License 1998 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2013-2014, 2016
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2014, 2016
- CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2013-2014, 2016
Clinical Trials
- Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
- DC Vaccine in Pancreatic Cancer Start of enrollment: 2018 Nov 20
Publications & Presentations
PubMed
- HLA-E single-chain trimer shields gene-edited allogeneic CAR T Cells from NK cell attack.Kimberly Apodaca, Chong Xu, Kelsey L Stanton, Miren L Baroja, Angel R Alfaro Doblado
Blood Advances. 2026-04-07 - Therapeutic scheduling of WEE1 inhibition preserves T cell function and promotes immune control of HPVtumors.Ying Liu, Zhiheng Zhang, Yanshan Tao, Lovely Rahgav, Sophie Gray-Gaillard
Biorxiv. 2026-03-17 - Antigen-specific profiling identifies T-betmelanoma-specific CD8T cells associated with response to neoadjuvant PD-1 blockade.Guanning Wang, Daniel Yoon, Ajeya Nandi, Khushboo Patel, Tarek Azar
Cancer Cell. 2026-01-12
Press Mentions
Awards & Accolades: July 2021August 4th, 2021- Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
- BostonGene, Abramson Cancer Center to Collaborate on Immunotherapy StudiesMay 11th, 2021
Grant Support
- PD-1 inhibition after Neoantigen VaccineNCIPresent
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
